Hybrigenics SA
Hybrigenics SA (ALHYG.PA) Stock Overview
Explore Hybrigenics SA’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.9M
P/E Ratio
-0.21
EPS (TTM)
$-0.04
ROE
-6.80%
ALHYG.PA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Hybrigenics SA (ALHYG.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.21 and a market capitalization of 3.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.
Léone Atayi
17
9 avenue du canal Philippe Lamour, Gallargues-le-Montueux
2007